AI
ASTX

Analytic Investors’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Analytic Investors’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-234,993
Closed -$2M – 627
2013
Q3 		$2M Buy
+234,993
New +$1.49M 0.03% 240

Analytic Investors's ASTX Position: Q4 2013 in Review

Analytic Investors sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 234,993 shares — an estimated $2M sold.

Analytic Investors first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $2M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Analytic Investors reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Analytic Investors sold 234,993 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $2M.
  • Analytic Investors first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • Analytic Investors's ASTEX PHARMACEUTICALS, INC COM position peaked at $2M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Analytic Investors's 13F filing for Q4 2013, filed 13 Feb 2014.